Sammy Khalifa - 03 Dec 2025 Form 4 Insider Report for Vicarious Surgical Inc. (RBOT)

Role: Chief Technology Officer, Director, 10%+ Owner
Signature: /s/ Sarah Romano, Attorney-in-Fact
Issuer symbol: RBOT
Transactions as of: 03 Dec 2025
Net transactions value: -$710
Form type: 4
Filing time: 04 Dec 2025, 19:13:22 UTC
Previous filing: 21 Nov 2025
Next filing: 24 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Khalifa Sammy	Chief Technology Officer, Director, 10%+ Owner	C/O VICARIOUS SURGICAL INC., 78 FOURTH AVENUE, WALTHAM	/s/ Sarah Romano, Attorney-in-Fact	04 Dec 2025	0001883777

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RBOT	Class A Common Stock	Sale	$710	-239	-0.71%	$2.97	33,623	03 Dec 2025	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2	This figure is the weighted average sales price of multiple trades ranging from $2.725 to $3.34 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

Content

The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on June 2, 2023. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

This figure is the weighted average sales price of multiple trades ranging from $2.725 to $3.34 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.